Jilin Province Huinan Changlong Bio-pharmacy Company Limited (HKG:8049)

Hong Kong · Delayed Price · Currency is HKD

2.290

-0.020 (-0.87%)

Jul 31, 2026, 3:11 PM HKT

HKG:8049 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	901.87	901.87	881.16	841.55	841.59	705.46
Revenue Growth	-2.70%	2.35%	4.71%	-0.01%	19.30%	13.37%
Gross Profit	757.67	757.67	685.25	584.05	648.04	579.27
Operating Income	215.42	215.42	184.63	160.64	158	140.63
Net Income	198.88	198.88	184.25	148.21	193.57	143.28
Earnings Per Share	0.35	0.35	0.33	0.26	0.35	0.26
EPS Growth	8.70%	7.94%	24.32%	-23.43%	35.09%	13.21%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	688.32	688.32	583.59	658.06	1,050	300.26
Total Debt	0.4	0.4	72.4	80.4	0.4	0.4
Net Cash (Debt)	687.92	687.92	511.19	577.66	1,049	299.86
Net Cash Growth	2.37%	34.57%	-11.51%	-44.95%	249.97%	5.90%
Net Cash Per Share	1.23	1.23	0.91	1.03	1.87	0.54

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	313.24	313.24	219.65	315.95	203.99	215.09
Capital Expenditures	-12.45	-12.45	-11.02	-31.84	-11.32	-92.84
Free Cash Flow	300.8	300.8	208.63	284.11	192.68	122.26
Free Cash Flow Growth	-	44.18%	-26.57%	47.45%	57.60%	133.03%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	84.01%	84.01%	77.77%	69.40%	77.00%	82.11%
Operating Margin	23.89%	23.89%	20.95%	19.09%	18.77%	19.93%
Pretax Margin	29.32%	29.32%	23.51%	23.57%	23.45%	25.13%
Profit Margin	22.05%	22.05%	20.91%	17.61%	23.00%	20.31%
FCF Margin	33.35%	33.35%	23.68%	33.76%	22.89%	17.33%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	5.80	5.52	3.94	5.63	2.23	3.76
P/FCF Ratio	3.83	3.65	3.48	2.94	2.24	4.41
PS Ratio	1.28	1.22	0.83	0.99	0.51	0.76